Menopause typically occurs between ages 49-52 and is defined as the permanent stopping of menstrual periods. Common symptoms include irregular periods, hot flashes, vaginal dryness and mood changes. Oral changes associated with menopause include burning mouth syndrome, dry mouth, pale atrophic mucosa, neurological disorders, and increased risk of osteoporosis and periodontitis due to hormonal changes. Management involves treating specific symptoms and reducing stress during dental procedures due to increased neurological issues.
Menopause typically occurs between ages 49-52 and is defined as the permanent stopping of menstrual periods. Common symptoms include irregular periods, hot flashes, vaginal dryness and mood changes. Oral changes associated with menopause include burning mouth syndrome, dry mouth, pale atrophic mucosa, neurological disorders, and increased risk of osteoporosis and periodontitis due to hormonal changes. Management involves treating specific symptoms and reducing stress during dental procedures due to increased neurological issues.
Menopause typically occurs between ages 49-52 and is defined as the permanent stopping of menstrual periods. Common symptoms include irregular periods, hot flashes, vaginal dryness and mood changes. Oral changes associated with menopause include burning mouth syndrome, dry mouth, pale atrophic mucosa, neurological disorders, and increased risk of osteoporosis and periodontitis due to hormonal changes. Management involves treating specific symptoms and reducing stress during dental procedures due to increased neurological issues.
MENOPAUSE also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children. Menopause typically occurs between 49 and 52 years of age. Medical professionals often define menopause as having occurred when a woman has not had any vaginal bleeding for a year. It may also be defined by a decrease in hormone production by the ovaries. In those who have had surgery to remove their uterus but they still have ovaries, menopause may be viewed to have occurred at the time of the surgery or when their hormone levels fell. Following the removal of the uterus, symptoms typically occur earlier, at an average of 45 years of age. MENOPAUSE Before menopause, a woman's periods typically become irregular, which means that periods may be longer or shorter in duration or be lighter or heavier in the amount of flow. During this time, women often experience hot flashes; these typically last from 30 seconds to ten minutes and may be associated with shivering, sweating, and reddening of the skin. Hot flashes often stop occurring after a year or two. Other symptoms may include vaginal dryness, trouble sleeping, and mood changes. MENOPAUSE
The severity of symptoms varies between women.
While menopause is often thought to be linked to an increase in heart disease, this primarily occurs due to increasing age and does not have a direct relationship with menopause. In some women, problems that were present like endometriosis or painful periods will improve after menopause. VAGINA AND UTERUS
During the transition to menopause, menstrual
patterns can show shorter cycling (by 2–7 days); longer cycles remain possible. There may be irregular bleeding (lighter, heavier, spotting).Dysfunctional uterine bleeding is often experienced by women approaching menopause due to the hormonal changes that accompany the menopause transition. Spotting or bleeding may simply be related to vaginal atrophy, a benign sore (polyp or lesion). AGE
In the Western world, the typical age of menopause
(last period from natural causes) is between 40 and 61 and the average age for last period is 51 years. The average age of natural menopause in Australia is 51.7 years. In India and the Philippines, the median age of natural menopause is considerably earlier, at 44 years. PREMATURE OVARIAN FAILURE (POF) is diagnosed or confirmed by high blood levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH) on at least three occasions at least four weeks apart. Women who have a functional disorder affecting the reproductive system (e.g., endometriosis, polycystic ovary syndrome, cancer of the reproductive organs) can go into menopause at a younger age than the normal timeframe. SURGICAL MENOPAUSE Menopause can be surgically induced by bilateral oophorectomy (removal of ovaries), which is often, but not always, done in conjunction with removal of the Fallopian tubes (salpingo- oophorectomy) and uterus (hysterectomy). Cessation of menses as a result of removal of the ovaries is called "surgical menopause". The sudden and complete drop in hormone levels usually produces extreme withdrawal symptoms such as hot flashes, etc. Removal of the uterus without removal of the ovaries does not directly cause menopause, PERIMENOPAUSE
which literally means "around the menopause", refers
to the menopause transition years, a time before and after the date of the final episode of flow. According to the North American Menopause Society, this transition can last for four to eight years. The Centre for Menstrual Cycle and Ovulation Research describes it as a six- to ten-year phase ending 12 months after the last menstrual period. THE TERM POSTMENOPAUSAL
describes women who have not experienced any
menstrual flow for a minimum of 12 months, assuming that they have a uterus and are not pregnant or lactating. In women without a uterus, menopause or postmenopause can be identified by a blood test showing a very high FSH level. Thus postmenopause the time in a woman's life that take place after her last period or, more accurately, after the point when her ovaries become inactive. ORAL CHANGES AT MENOPAUSE AND PROSTHODONTIC IMPLICATIONS The oral alterations noted at menopause are frequently related to hormonal changes although a physiological aging of the oral tissues also plays a contributing role. The following are the oral manifestations noted at menopause: Burning mouth syndrome; Xerostomia; Mucosal changes; Neurological disorders; Osteoporosis and periodontitis; Eating disorders BURNING MOUTH SYNDROME Burning mouth syndrome (BMS) also known as glossodynia, stomatodynia, stomatopyrosis, glossopyrosis, glossalgia represents a common oral abnormality that manifests as intense pain and spontaneous burning sensation affecting various areas of the oral cavity in the absence of any identifiable organic abnormalities. It is chiefly bilateral and affects the tongue, lips, palate, gingival, and areas of denture support. BURNING MOUTH SYNDROME According to a study conducted by Wardropa and co-workers, 33% of postmenopausal women studied reported oral discomfort in the absence of other oral changes. Furthermore, the prevalence of oral discomfort was found to be appreciably higher in peri/postmenopausal women than in premenopausal women (43% vs.6%).Accompanying oral alterations include disgeusya, dry mouth, dysphagia, and oro-facial/dental pain. BURNING MOUTH SYNDROME The underlying etiology remains ambiguous with hormonal changes and small- fiber sensory neuropathy of the oral mucosa suggested as probable underlying causes.[6] Variable results have been obtained following treatment of BMS in menopausal women with hormone replacement therapy (HRT), low-dose topical/systemic clonazepam, psychological counseling, and tricyclic antidepressants. XEROSTOMIA Hyposialia, xerostomia or dryness of mouth is yet another symptom frequently manifested by menopausal women. Although few studies conclude that salivary flow decreases in menopausal women with increase in salivary IgA and total proteins, others have not been able to delineate any alterations in salivary volume/composition. Some studies further implicate decreased salivary flow as a cause for increased incidence of root caries, oral discomfort, taste alterations, oral candidiasis, and periodontal disease in menopausal women. In addition, Sjogren's syndrome an autoimmune disorder leading to xerostomia, keratoconjunctivitis sicca, vaginal dryness and dyspareunia is found to occur with a higher frequency in menopausal women. MANAGEMENT
• includes frequent sipping of water, artificial salivary
substitutes, sugar free-gums/lozenges, xylitol tablets and sialogogues such as pilocarpine, bromhexine, cevimeline, and bethanecol. Use of toothpastes, gels/varnishes containing fluorides is advisable for prevention of dental caries. Chlorhexidine reduces plaque and enables prevention of root caries. MUCOSAL CHANGES The oral mucosa is in several ways akin to the vaginal mucosa. The oral mucosal changes may thus range from a condition referred to as “menopausal gingivostomatitis” to an atrophic pale appearing mucosa.Menopausal gingivostomatitis is characterized by gingiva that bleed readily, with an abnormally pale dry/shiny erythematous appearance. These symptoms necessitate a scrupulous assessment of denture fit and evaluation of the status of underlying tissues to eliminate chronic irritation. If fungal culture proves positive, topical antifungal agents such as clotrimazole or nystatin may provide relief from symptoms. Hormonal therapy with estradiol in patients with identifiable estrogen receptors at the oral epithelial level may be beneficial NEUROLOGICAL DISORDERS
Trigeminal neuralgia is also known to occur frequently in postmenopausal
women owing to compression of superior cerebellar artery on any one of the branches of trigeminal nerve. The same is characterized by severe unilateral, lancinating, “electric-shock” like pain usually in the middle and lower third of the face. Apart from this other neurological disorders such as Alzheimer's disease and atypical facial pain/neuralgia may affect postmenopausal women. Neurological disorders influence impression making procedures, jaw relation records, and denture retention. Thus, employment of anxiety and stress- reduction protocols is suggested in menopausal women during treatment procedures. OSTEOPOROSIS AND PERIODONTITIS
The susceptibility to progressive periodontitis and osteoporosis enhances
following menopause. The exact pathogenesis remains unclear although increased accumulation of bacterial plaque and estrogen/serum osteocalcin deficiency have been suggested as etiological factors.Systemic osteoporosis leading to generalized bone loss may make the jaws susceptible to advanced alveolar bone loss, decreased bone mineral density (BMD) OSTEOPOROSIS Women with advanced osteoporosis were thrice more susceptible to be edentulous than healthy age-matched controls.Thus, the probability of a Prosthodontist treating menopausal women would be high, making a knowledge of the oral and systemic symptoms in women of menopausal age imperative. Methods of diagnosing systemic osteoporosis in postmenopausal women have been developed by oral and maxillofacial radiologists employing dental/panoramic radiographs. OSTEOPOROSIS
Bisphosphonates prevent systemic bone resorption and
decrease the incidence of vertebral and nonvertebral fractures in postmenopausal women. Alendronate and Risedronate have found to improve periodontal status in particular. Numerous cases reports have associated use of bisphosphonates to osteonecrosis of the jaws. However, according to the doses of bisphosphonates for treating osteoporosis are recommended by FDA EATING DISORDERS
psychological distress in menopausal women may lead to eating disorders.
Oral changes may crop from self-induced vomiting and resultant regurgitation of gastric contents. Smooth erosion of enamel, perimolysis, enlarged parotid glands, trauma to oral mucous membrane and pharynx resulting from use of fingers, combs, and pen to induce vomiting, dehydration, and erythema may be observed in menopausal women suffering from eating disorders. • Thank you for attention